Condition
Vulval Cancer
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06694116Not ApplicableActive Not RecruitingPrimary
Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar Cancer
NCT04952961Not ApplicableCompleted
Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
NCT02458001Not ApplicableUnknown
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
NCT00604994Completed
Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
Showing all 4 trials